Orit Picard - Publications

Transcriptomic profiling of fecal aspirates as a tool for prediction of endoscopic inflammation in small bowel Crohn's disease.

Journal: Journal of Crohn's & colitis

Published: March 25, 2026

A national consensus guideline on the performance and interpretation of hydrogen- and methane-based breath tests for carbohydrate malabsorption, small intestinal bacterial overgrowth, and intestinal methanogen overgrowth.

Journal: Annals of gastroenterology

Published: January 08, 2026

Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled study.

Journal: Gastroenterology report

Published: September 18, 2025

Perturbations of Diet and Gut Signatures Persist During Remission in Crohn's Disease Despite Effective Immune Suppression.

Journal: Gastroenterology

Published: July 16, 2025

Fecal metabolic signals are associated with changes in microbiota and systemic metabolic pathways in Crohn's disease.

Journal: Scientific reports

Published: June 24, 2025

Overcoming anti-Infliximab antibodies and maintaining Infliximab achieves superior durability and outcome compared to switching to Adalimumab.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 19, 2025

Fecal and Serum Metabolome in Crohn's Disease is Linked With Future Flare.

Journal: United European gastroenterology journal

Published: March 05, 2025

Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma.

Journal: Cancer medicine

Published: May 17, 2024

Diet-omics in the Study of Urban and Rural Crohn disease Evolution (SOURCE) cohort.

Journal: Nature communications

Published: October 11, 2023

Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.

Journal: Journal of Crohn's & colitis

Published: July 11, 2023

Baseline Peripheral Blood Mononuclear Cell Transcriptomics Before Ustekinumab Treatment Is Linked With Crohn's Disease Clinical Response at 1 Year.

Journal: Clinical and translational gastroenterology

Published: May 14, 2023

Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?

Journal: Biomedicines

Published: March 30, 2023